XQQ-59545-05635
2 vaccinations
1 coded response
5 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 331 / FL
- Registered
- 2022-02-09
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-01-20
Dose 1 — Pfizer-BioNTech
-
2022-02-09
Registered in v-safe
-
2022-02-09
Dose 2 — Pfizer-BioNTech
- 2022-02-09
-
2022-02-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-02-12
- 2022-03-11
-
2022-03-17
Survey response — day 35, dose 2MedDRA: Influenza like illness — Feeling: FairFree text: Flu like symptoms.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-01-20 | Pfizer-BioNTech | No |
| 2 | 2022-02-09 | Pfizer-BioNTech | No |
Free text
Release 11 — day 35, dose 2
Symptoms: Flu like symptoms.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza like illness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release